Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Centene Corporation    CNC

CENTENE CORPORATION

(CNC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Higher medical costs take shine off Cigna second-quarter profit beat

share with twitter share with LinkedIn share with facebook
share via e-mail
08/01/2019 | 12:35pm EDT
A screen displays the logo fro Cigna Corp. on the floor at the NYSE in New York

(Reuters) - Health insurer Cigna Corp raised its 2019 profit forecast on Thursday, helped by last year's acquisition of pharmacy benefit manager Express Scripts, but medical costs in the second quarter were higher than expected and its shares fell slightly.

As health insurers face regulatory uncertainty amid political efforts to lower U.S. healthcare costs ahead of the 2020 presidential election, Cigna is hoping the $52 billion acquisition will help rein in its own costs.

In the quarter, however, Cigna's medical care ratio - the percentage of premiums paid out for medical services - was 81.6%, above the 80.2% estimated analysts, according to Refinitiv data.

The company did report higher-than-expected earnings.

Bernstein analyst Lance Wilkes said that was mostly due to the pharmacy benefits business, while investors were likely focusing on the insurance side. "The higher valuation health insurance unit has some questions from medical costs and membership growth rate," Wilkes said.

Medical costs have been an issue for the sector, with rivals like Centene Corp and Anthem Inc also missing expectations.

Cigna Chief Executive David Cordani said in an interview that the company's costs are growing within expectations, and that several factors influenced the ratio.

He cited lowered premium rates in its individual insurance business, the suspension of an industry-wide insurance fee and higher costs from Express Scripts drug plans.

"Costs relative to any industry measure are extremely positive," Cordani said.

As the 2020 presidential campaign heats up among potential Democratic challengers to U.S. President Donald Trump, proposals by some candidates for Medicare-For-All programs that would eliminate private insurance has cast a pall of uncertainty over the sector.

Republican Senator Charles Grassley and Democrat Ron Wyden are also pushing legislation that aims to cut $100 billion in costs to government healthcare programs.

Cordani said Cigna is engaged in Washington policy discussions and that it backs aspects of that bill, such as preventing patients from receiving surprising medical bills.

Cigna earned $4.19 per share excluding items for the quarter, beating Wall Street estimates of $3.74, according to Refinitiv IBES.

Cigna now expects 2019 adjusted income of $16.60 to $16.90 per share, up from its prior view of $16.25 to $16.65.

Adjusted revenue from the health services unit, which now includes Express Scripts pharmacy benefits, rose to $23.54 billion from $1.11 billion last year.

However, Cigna said earnings were lower than comparable results from Express Scripts' second quarter in 2018.

Cigna shares were down 0.3% at $169.40.

(Reporting by Aakash Jagadeesh Babu and Tamara Mathias in Bengaluru and Caroline Humer in New York; Editing by Shailesh Kuber and Bill Berkrot)

By Tamara Mathias and Caroline Humer

Stocks mentioned in the article
ChangeLast1st jan.
ANTHEM, INC. -5.39% 222.96 Delayed Quote.-26.18%
CENTENE CORPORATION -5.49% 55.1 Delayed Quote.-12.36%
CIGNA CORPORATION -4.87% 161.29 Delayed Quote.-21.13%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CENTENE CORPORATION
03/12CENTENE : Taking Additional Steps To Protect Members' Health Amid COVID-19 Outbr..
PR
03/05Health Care Down As UnitedHealth Group, Managed Care Cos Give Back Some Gains..
DJ
03/04CENTENE : 2020 Consolidated Guidance Conference Call
PU
03/04WALL STREET STOCK EXCHANGE : Stocks Close Sharply Higher on Virus Spending, Bide..
DJ
03/04Health-Care Stocks Are Big Super Tuesday Winner
DJ
03/04Health Insurers Trade Higher After Biden Victories
DJ
03/04CENTENE : Subsidiary Awarded Correctional Contracts For Medical And Behavioral H..
PR
03/04CENTENE : Thinking about buying stock in Ambarella, Cigna, Centene Corp, Inovio ..
PR
03/03CENTENE CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
03/03CENTENE CORPORATION : Announces Updated 2020 Guidance
PR
More news
Financials (USD)
Sales 2020 106 B
EBIT 2020 4 295 M
Net income 2020 1 994 M
Debt 2020 7 635 M
Yield 2020 -
P/E ratio 2020 16,4x
P/E ratio 2021 11,8x
EV / Sales2020 0,38x
EV / Sales2021 0,32x
Capitalization 32 333 M
Chart CENTENE CORPORATION
Duration : Period :
Centene Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CENTENE CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Average target price 79,43  $
Last Close Price 55,10  $
Spread / Highest target 86,9%
Spread / Average Target 44,1%
Spread / Lowest Target 10,7%
EPS Revisions
Managers
NameTitle
Michael F. Neidorff Chairman, President & Chief Executive Officer
Brandy Burkhalter Chief Operating Officer & Executive Vice President
Jeffrey A. Schwaneke Chief Financial Officer, Treasurer & Executive VP
Mary V. Mason Chief Medial Officer & Senior Vice President
Ken Yamaguchi Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CENTENE CORPORATION-12.36%32 333
UNITEDHEALTH GROUP-17.53%229 982
CIGNA CORPORATION-21.13%59 987
ANTHEM, INC.-26.18%56 217
HUMANA INC.-16.93%39 250
WELLCARE HEALTH PLANS5.97%17 611